Multimodality assessments of wild‐type transthyretin cardiac amyloidosis with no ventricular hypertrophy

Multimodality assessments of wild‐type transthyretin cardiac amyloidosis with no ventricular hypertrophy

Abstract While patients with transthyretin cardiac amyloidosis (ATTR‐CA) typically present with concentric or asymmetric hypertrophy, a small percentage of ATTR‐CA is known to present with ‘atypical’ cardiac morphologies such as eccentric hypertrophy or even no hypertrophy. However, detailed report...

Full description

Bibliographic Details
Main Authors: Takuma Iwaya, Atsushi Okada, Emi Tateishi, Yasutoshi Ohta, Yoshiaki Morita, Keiko Ohta‐Ogo, Chisato Izumi
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:ESC Heart Failure
Subjects:
Amyloid cardiomyopathy
Pyrophosphate scintigraphy
False negative
Tafamidis
Heart failure
Cardiovascular magnetic resonance
Online Access:https://doi.org/10.1002/ehf2.14220

Internet

https://doi.org/10.1002/ehf2.14220

Similar Items